Laboratoire Aguettant
Eric Rougemond is the Chief Executive Officer of Laboratoire Aguettant, PROMISE Advanced Proteomics, and was previously the CEO of PX'Therapeutics. Prior to these roles, Eric held various leadership positions in EUSA Pharma, including Vice President for multiple regions. With a background in medical and clinical affairs, Eric has extensive experience in oncology, neurology, critical care, and orphan drugs. With a strong focus on P&L management and business development, Eric has also managed teams and partnerships in his various roles. Having obtained a Degree in Management of Pharmaceutical Industry and a Doctor of Medicine degree, Eric Rougemond has a well-rounded background in the pharmaceutical industry.
Laboratoire Aguettant
2 followers
Aguettant is a family-owned pharmaceutical company dedicated to the development, industrial production and distribution of innovative injectable pharmaceutical specialties that meet the demands and the needs of healthcare professionals and patients. Basé à Lyon en France, AGUETTANT est un laboratoire pharmaceutique familial dédié au développement, à la fabrication et à la commercialisation de spécialités pharmaceutiques injectables utilisées ou initiées à l’hôpital. Acteur européen reconnu, AGUETTANT met son expertise au service du progrès et de l’innovation médicale pour concevoir les solutions thérapeutiques de demain.